BlueCloud follows the Uber model to streamline connections

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/ bogdan kosanovic)
(Image: Getty/ bogdan kosanovic)

Related tags: Research, Site selection, Clinical trial, CRO, Health care, CRO market, research network

BlueCloud by HealthCarePoint releases DDIT mechanisms to create an Uber-like service for the health care industry – connecting providers and consumers, such a sponsors and CROs.

BlueCloud, an independent network system​ for health care and clinical research created by HealthCarePoint, this week announced the addition of its delivery, distribution, implementation, and tracking (DDIT) mechanisms.

President of BlueCloud Al Pacino told us that the addition of the DDIT applications to its global system allows the collaborative network to operate like Uber: Connecting providers like investigative trial sites, to industry consumers such as sponsors and contract research organizations (CROs).

The network also added the DDIT mechanisms in an aim to “modernize the health care and clinical research ecosystem using basic business and compliance principles and modern technology models, by simply connecting industry consumers,” ​Pacino said. Each mechanism or application is designed to streamline a component of clinical research

The delivery and distribution mechanisms within the BlueCloud system enable consumers to find the products, services, and technologies needed for clinical research through authorized channels. It also provides patient maps to help locate potential clinical trial participants, among other applications and tools to help connect providers and consumers.

“Whenever the sponsors need to identify investigative sites for their clinical trial they should not have to pay for the list of investigative sites or the directories of thousands of professionals at the sites in order to do site screening and have site accessibility, it’s free to the sponsor as a consumer.

"Sponsors then use the BlueCloud DDIT on-demand mechanisms to properly identify the investigative sites that they’re going to choose for their clinical. Once they chose their sites, just like Uber once we chose our driver, sponsors are able to connect to their chosen sites immediately using their own BlueCloud system and perform site competencies, feasibility and other screening activities at no cost to the sponsor,” ​Pacino explained.

Additionally, a centralized global tracking system keeps tabs on regulatory compliance.

Pacino said, “The BlueCloud System looks to modernize all aspects of healthcare and clinical research not just creating a temporary solution for a single problem. By modernizing the complete ecosystem the industry can ultimately be sustainable - when opportunities are provided to every stakeholder – everyone win.”

Related news

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Because When It's On the Line... Capability Matters.

Because When It's On the Line... Capability Matters.

Baxter BioPharma Solutions | 01-Oct-2022 | Product Brochure

Baxter’s BioPharma Solutions business supports leading pharmaceutical companies in meeting their commercialization objectives by providing scientific expertise,...

Related suppliers

Follow us


View more